Denali Therapeutics Inc. (4DN.F)
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.
20.72+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+72.7%
The outlook
Denali Therapeutics Inc. currently reads as bullish based on above its 50- & 200-day averages, 78% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range78% of the way from its 52-week low to high
Market cap
$3.29B
52-wk high
23.47
52-wk low
10.79
50-day avg
19.75
200-day avg
16.97
Trailing P/E
—